# TYVASO DPI
> **NDA214324** · New Drug Application · Sponsor: UNITED THERAP · Approved 2022-05-23
## Drug
- **FDA Application Number:** NDA214324
- **Application type:** New Drug Application
- **Brand name:** TYVASO DPI
- **Generic name:** TREPROSTINIL
- **Active ingredients:** TREPROSTINIL
- **Dosage form:** POWDER
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** UNITED THERAP
- **Manufacturer:** United Therapeutics Corporation
- **First approval:** 2022-05-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214324)
---
*AI Analytics · CC0 1.0*